ALFALASTIN 33.33 mg/ml, powder and solvent for solution for injection bottle, 120 ml
Active ingredients: ALPHA-1 ANTITRYPSINE HUMAINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 120 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALFALASTIN 33,33 mg/mL, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 flacon(s) en verre de 120 mL avec dispositif(s) de transfert avec filtre(s) avec matériel(s) de perfusion muni d'un filtre
- Marketing authorisation holder
- LFB-BIOMEDICAMENTS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Apr 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60153239CIP75793761CIP133400957937614Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALPHA-1 ANTITRYPSINE HUMAINEpoudre | 33,33 mg · 1 mL de solution reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.